Guglielmini P, Serao A, Zai S, Piovano P, Grosso F. Second-line treatment with Axitinib: an effective and well-tolerated weapon in the therapeutic sequence of clear cell renal cell carcinoma. Work Paper Public Hlth [Internet]. 2015 Jun. 15 [cited 2024 Nov. 22];4(1). Available from: https://www.pagepress.org/journals/wpph/article/view/6697